Try our beta test site
48 studies found for:    Open Studies | "Streptococcal Infections"
Show Display Options
Rank Status Study
21 Recruiting An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department
Condition: Pneumococcal Infections
Intervention:
22 Recruiting Evaluation of Fetal Cardiac Function in Rheumatic Heart Disease (RHD) Patients
Condition: Fetal Distress
Intervention:
23 Recruiting Enhancing a Sustainable Pharmacy-based Immunization Program in Two States
Conditions: Herpes Zoster;   Pneumococcal Infections
Interventions: Behavioral: Enhanced immunization delivery model;   Other: Immunization update
24 Recruiting Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
Conditions: Infections, Pneumococcal;   Bowel Diseases, Inflammatory
Interventions: Biological: Prevenar 13;   Biological: Pneumo 23
25 Recruiting Aerosolized and Intravenous Colistin in Healthy Adults
Conditions: Pneumococcal Infection;   Pneumonia;   Pathogen Resistance
Intervention: Drug: Colistimethate sodium
26 Recruiting Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
Condition: Pneumococcal Diseases
Intervention: Other: There is no intervention in this study
27 Recruiting Study Medication Adherence and Its Determinants in Chronic Disease Through the Example of Methotrexate in Chronic Inflammatory Rheumatism
Condition: Rheumatic Diseases
Intervention:
28 Not yet recruiting Efficacy of BLIS K12 as Preventive Measure for Rheumatic Children
Condition: Rheumatic Fever
Intervention: Dietary Supplement: Streptococcus Salivarius BLIS K12
29 Recruiting Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
Conditions: Pneumonia;   Pneumococcal Infections
Interventions: Drug: CAL02 Low-dose;   Drug: CAL02 High-dose;   Drug: Placebo
30 Not yet recruiting Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
Conditions: Endocardits, Bacterial;   Opioid-use Disorder;   Buprenorphine;   Outpatient Parenteral Antibiotic Therapy
Interventions: Drug: Buprenorphine/naloxone;   Other: Outpatient parenteral antibiotic therapy
31 Not yet recruiting Evaluation of PCV Schedules in a Naive Population in Vietnam
Condition: Pneumonia, Pneumococcal
Interventions: Biological: PCV 2p+1;   Biological: PCV 3p+0;   Biological: PCV 1p+1;   Biological: PCV 0p+1
32 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (20 mg);   Drug: Vitamin K antagonists (VKA)
33 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (15 mg);   Drug: Aspirin
34 Recruiting Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma;   Pneumococcal Infections
Interventions: Biological: Prevenar 13;   Biological: Immunovac;   Drug: Polioxidonium;   Biological: Pneumo-23
35 Recruiting Long-term Clinico-radiological Evolution of Patients With Brain Lesions During Infectious Endocarditis
Condition: Infectious Endocarditis
Intervention: Other: Magnetic resonance imaging
36 Recruiting The Genetic Basis of Acquired Heart Disease in Africa
Conditions: Rheumatic Heart Disease;   Rheumatic Fever;   Endomyocardial Fibrosis;   Acquired Heart Disease
Intervention:
37 Recruiting RhEumatiC Heart diseAse Genetics
Condition: Rheumatic Heart Disease
Intervention: Genetic: Next generation sequencing
38 Not yet recruiting Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
Condition: Invasive Pneumococcal Infection
Interventions: Biological: PCV13;   Biological: PPV23;   Drug: Rituximab
39 Recruiting Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
Conditions: Pneumococcal Infection;   ANCA-associated Vasculitis
Intervention:
40 Recruiting Protection Against Pneumococcal Infection in Children With T1DM
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: 13-valent pneumococcal conjugate vaccine (PCV13)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-48) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.